Genmab A/S 2015 SR
The report outlines Genmab's CSR strategy for 2015, focusing on employee well-being, ethics in clinical studies, environmental impact, and business ethics. Key highlights include the launch of a leadership development program, a global employee survey with an 86% response rate, and progress toward increasing female board representation to 20%. The company also emphasized its commitment to high ethical standards in drug development and waste management. Genmab continues to align its operations with its 2025 vision to transform cancer treatment through innovative antibody products.
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2015
Type: SR
Pages: 8
Back to company
Genmab A/S
Corporate Social Responsibility Report
The report outlines Genmab's CSR strategy for 2015, focusing on employee well-being, ethics in clinical studies, environmental impact, and business ethics. Key highlights include the launch of a leadership development program, a global employee survey with an 86% response rate, and progress toward increasing female board representation to 20%. The company also emphasized its commitment to high ethical standards in drug development and waste management. Genmab continues to align its operations with its 2025 vision to transform cancer treatment through innovative antibody products.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees